Rhinovirus prevalence as indicator for efficacy of measures against SARS-CoV-2.

ABSTRACT:

Background

Non-pharmaceutical measures to control the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) should be carefully tuned as they can impose a heavy social and economic burden. To quantify and possibly tune the efficacy of these anti-SARS-CoV-2 measures, we have devised indicators based on the abundant historic and current prevalence data from other respiratory viruses.

Methods

We obtained incidence data of 17 respiratory viruses from hospitalized patients and outpatients collected by 37 clinics and laboratories between 2010-2020 in Germany. With a probabilistic model for Bayes inference we quantified prevalence changes of the different viruses between months in the pre-pandemic period 2010-2019 and the corresponding months in 2020, the year of t

SUBMITTER: Kitanovski S 

PROVIDER: S-EPMC8215636 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature